These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases. Xu J, Cai H, Zheng X. BMC Infect Dis; 2023 Apr 03; 23(1):199. PubMed ID: 37013474 [Abstract] [Full Text] [Related]
10. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study. Kulesza S, Gignac L, Colvin CA, Boll S, Giuliano C, Haan B, Allen B, Perez MM, Allen M, Edwin SB. Pharmacotherapy; 2023 Aug 03; 43(8):787-794. PubMed ID: 37148191 [Abstract] [Full Text] [Related]
11. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience. Russell JA, Lee T, Singer J, Boyd JH, Walley KR, Vasopressin and Septic Shock Trial (VASST) Group. Crit Care Med; 2017 Jun 03; 45(6):940-948. PubMed ID: 28333757 [Abstract] [Full Text] [Related]
12. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database. He D, Zhang L, Hu H, Gu WJ, Lu X, Qiu M, Li C, Yin H, Lyu J. Am J Emerg Med; 2023 Jul 03; 69():188-194. PubMed ID: 37167890 [Abstract] [Full Text] [Related]
15. Predictors of Vasopressin Responsiveness in Critically Ill Adults. Allen B, Kram B, Kram S, Schultheis J, Wolf S, Gilstrap D, Shapiro M. Ann Pharmacother; 2018 Feb 03; 52(2):126-132. PubMed ID: 28853293 [Abstract] [Full Text] [Related]
16. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Crit Care Med; 2022 Apr 01; 50(4):614-623. PubMed ID: 34582425 [Abstract] [Full Text] [Related]
17. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. J Intensive Care Med; 2019 Oct 01; 34(10):805-810. PubMed ID: 28618919 [Abstract] [Full Text] [Related]
18. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial. Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, Park CHL, Fukushima JT, Rizk SI, Szeles TF, Dos Santos Neto NC, Filho RK, Galas FRBG, Landoni G. Crit Care Med; 2019 Dec 01; 47(12):1743-1750. PubMed ID: 31609774 [Abstract] [Full Text] [Related]
19. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review. Sacha GL, Bauer SR. Chest; 2023 Nov 01; 164(5):1216-1227. PubMed ID: 37479058 [Abstract] [Full Text] [Related]
20. Vasopressin Initiation as a Second-Line VasoPressor in Early Septic Shock (VISPSS). Ragoonanan D, Nickelsen P, Tran N, Allen B, Emborski R, Legare A, Villela A, Hampson L, Busey K, Shomo E, Broomfield A, Hailu K. J Intensive Care Med; 2024 Apr 01; 39(4):306-312. PubMed ID: 37715634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]